With the global rise of liver diseases, the impact of the TRIF molecule in diverse liver pathologies has gained significant momentum, including viral hepatitis, metabolic dysfunction-associated steatohepatitis (MASH), alcoholic hepatitis, and more. The gene discussed is TICAM1; the disease is liver disorder.